Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west

J Lu, XP Zhang, BY Zhong, WY Lau… - The lancet …, 2019 - thelancet.com
Portal vein tumour thrombosis is common among patients with advanced hepatocellular
carcinoma. Tremendous differences exist in the management of hepatocellular carcinoma …

Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 Edition)

S Cheng, M Chen, J Cai, J Sun, R Guo, X Bi, WY Lau… - Liver cancer, 2020 - karger.com
Portal vein tumor thrombus (PVTT) is very common, and it plays a major role in the
prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the …

[HTML][HTML] Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China (2021 edition)

J Sun, R Guo, X Bi, M Wu, Z Tang, WY Lau, S Zheng… - Liver Cancer, 2022 - karger.com
Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis
and clinical staging of hepatocellular carcinoma (HCC). We have published the first version …

Concepts and controversies in haemostasis and thrombosis associated with liver disease: Proceedings of the 7th International Coagulation in Liver Disease …

NM Intagliata, CK Argo, JG Stine… - Thrombosis and …, 2018 - thieme-connect.com
Patients with acute and chronic liver disease frequently acquire unique changes in
haemodynamic and haemostatic pathways that may result in life-threatening bleeding and …

Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis

I Pettinari, R Vukotic, H Stefanescu… - Official journal of the …, 2019 - journals.lww.com
Objectives: Portal vein thrombosis (PVT) is a frequent complication of cirrhosis. Benefit,
safety, and duration of anticoagulant treatment in this setting are controversial issues. The …

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

L Naymagon, D Tremblay, N Zubizarreta… - Blood …, 2020 - ashpublications.org
Guidelines currently favor vitamin K antagonists or low-molecular-weight heparins for
treatment of noncirrhotic portal vein thrombosis (ncPVT). Use of direct oral anticoagulants …

Pretransplant portal vein recanalization—transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis

R Salem, M Vouche, T Baker, JI Herrero… - …, 2015 - journals.lww.com
Background Chronic, obliterative portal vein (PV) thrombosis (PVT) represents a relative
contraindication to liver transplantation (LT) in some centers. When PV …

Incidence and treatment of splanchnic vein thrombosis in patients with acute pancreatitis: a systematic review and meta‐analysis

FS Anis, A Adiamah, DN Lobo… - … of Gastroenterology and …, 2022 - Wiley Online Library
Abstract Background and Aim This meta‐analysis aimed to estimate the incidence of
splanchnic vein thrombosis (SVT) in patients with acute pancreatitis and assess the effects …

portal vein obstruction–epidemiology, pathogenesis, natural history, prognosis and treatment

A Kumar, P Sharma, A Arora - Alimentary pharmacology & …, 2015 - Wiley Online Library
Background Portal vein obstruction may be due to portal vein thrombosis (PVT) or its
sequale, the portal cavernoma. PVT is a common complication in liver cirrhosis, however, it …

Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model

Y Li, J Gao, X Zheng, G Nie, J Qin… - Briefings in …, 2024 - academic.oup.com
Background Portal vein thrombosis (PVT) is a significant issue in cirrhotic patients,
necessitating early detection. This study aims to develop a data-driven predictive model for …